MicroRNA silencing and the development of novel therapies for liver disease. - Wikidata - awgldk - TriplyDB

MicroRNA silencing and the development of novel therapies for liver disease.

MicroRNA silencing and the development of novel therapies for liver disease.

http://www.wikidata.org/entity/Q38002726

about

Hepatoprotective Effects of Chinese Medicinal Herbs: A Focus on Anti-Inflammatory and Anti-Oxidative Activities MicroRNAs in liver disease Micro-RNA-155 deficiency prevents alcohol-induced serum endotoxin increase and small bowel inflammation in mice.microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis.Liver cancer oncogenomics: opportunities and dilemmas for clinical applications.MiRNA-211 suppresses cell proliferation, migration and invasion by targeting SPARC in human hepatocellular carcinoma Identification of microRNAs specifically expressed in hepatitis C virus-associated hepatocellular carcinoma.Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression.The microRNAs as potential biomarkers for predicting the onset of aflatoxin exposure in human beings: a review.miR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1/PTEN/Akt pathway.Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis.

P2860

Q26752622-2ABC92E5-42D6-4A63-AE5E-58C379362ED2 Q33880442-4374B661-DAD7-4124-8F93-6740E3173CF5 Q34659613-C8FDF6F6-1208-4956-AA8A-0E3CC508F738 Q34899647-2F092A6E-9C6C-4DEF-9325-042D224ADE6D Q35913384-DBEB5FF8-DA64-459F-865B-983DCFCF956B Q36941240-4087D516-4E44-4395-ACCE-FDD9510B1614 Q37316633-18FB0045-ADD1-464C-B3EC-3CE1E25D6B38 Q37398932-009EE601-B90E-4F8E-BA68-D25CC66673F0 Q37642381-0D109C17-A655-4489-A13C-5D213029A17B Q38986675-A2EEB35A-1B4E-4202-9C4D-A44F4AD32352 Q42367659-2E3907A2-1A5E-406E-A11D-94A95728466B

P2860

MicroRNA silencing and the development of novel therapies for liver disease.

http://www.wikidata.org/entity/Q38002726

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

MicroRNA silencing and the development of novel therapies for liver disease.

@en

type

label

MicroRNA silencing and the development of novel therapies for liver disease.

@en

prefLabel

MicroRNA silencing and the development of novel therapies for liver disease.

@en

P1433

Q38002726-3011256C-5D9D-408C-A8BD-F6EFA00C85DF

P1476

Q38002726-D2910BE4-7ABE-4E69-AA5F-F4A8DC042F3E

P2093

Q38002726-96B6168C-9876-4E3E-8822-6C5652D2CA39

Q38002726-AC9DFD1F-3DC8-4FE6-B7C1-9B94044EC743

Q38002726-B63D9667-C46D-425E-92D3-0768E3AC7610

P2860

Q38002726-06FEC003-1FB7-47DC-A134-D949594A7E58

Q38002726-09012510-DCE2-4786-815F-AF920E59F1C2

Q38002726-1AB3DE13-63F9-4128-A563-C0571851F5C1

Q38002726-1AC51540-C934-44A6-9007-1B8EAD77691A

Q38002726-2B8010C2-4ED9-457F-9F0E-EACD6101E49D

Q38002726-2F1B2A24-2FCB-490E-8827-F74C62A0B050

Q38002726-3BD51100-5CEE-421D-A298-1580381A6485

Q38002726-3C5D0A01-B4DF-43A7-877E-D71679794BF3

Q38002726-41A62C0F-C26C-4960-A448-F1B63723C102

Q38002726-42E4420E-8B1C-4DE7-8CC2-34F403DED684

P304

Q38002726-F744D84E-AF8F-4C5E-8076-6BBBC588D100

P31

Q38002726-744F0A5B-8B96-4D86-A868-E6905E84BDB9

P356

Q38002726-6A1136C2-F584-4836-A914-48006E0ACCD9

P433

Q38002726-F86FB018-0DFC-4886-AB21-98EC3F564456

P478

Q38002726-C0CF1DB6-5709-454E-8600-4B12BB8246B1

P577

Q38002726-73558C30-283E-48A9-8436-75EE2324FBBD

P5875

Q38002726-559F5B9B-D11C-4E53-A2D1-0AE256D9DC80

P698

Q38002726-EFA344F5-2BC5-4721-999B-8E5346B84DA3

P921

Q38002726-1932E724-9AFE-496D-B231-231B3B6AA059

P932

Q38002726-008063FA-35E7-428D-85E8-37483E6F2546

P356

J.JHEP.2012.01.030

P1433

Journal of Hepatology

P1476

MicroRNA silencing and the development of novel therapies for liver disease.

@en

P2093

Gyongyi Szabo

http://www.w3.org/2001/XMLSchema#string

Peter Sarnow

http://www.w3.org/2001/XMLSchema#string

Shashi Bala

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNAs: target recognition and regulatory functions

MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis

Widespread microRNA repression by Myc contributes to tumorigenesis

Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

Integration of microRNA miR-122 in hepatic circadian gene expression

Emerging role of microRNAs in liver diseases

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA

miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting

P304

462-466

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JHEP.2012.01.030

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224038129

http://www.w3.org/2001/XMLSchema#string

P698

22504335

http://www.w3.org/2001/XMLSchema#string

P921

P932

4186651

http://www.w3.org/2001/XMLSchema#string